Health Care·Health Care Equipment·$4.4B
Envista Holdings Corp (NVST) operates in the health care equipment sector, focusing on dental products and technologies. As a player in the health care industry, its performance can be influenced by trends in consumer spending and advancements in medical technology.
EPS
Earnings per share is a critical measure of profitability and will indicate how well the company is managing costs and generating income.
Revenue
Total revenue reflects the company's sales performance and demand for its products, which is essential for assessing growth.
Wall Street expectations, options signals, track record, and call prep available with Pro.
EPS Beat Streak
6Q
EPS Beat Rate
75%
Avg EPS Surprise
+4.42%
Avg Stock Reaction
+0.43%
In Q4-2025, Envista reported an EPS of $0.38, exceeding expectations and showing strong performance. The stock reacted positively, gaining 4.44% the following day.
Management Promises & Guidance
Analysts are expecting Envista to report an EPS of $0.31 and revenue of $680 million for Q1-2026, reflecting steady growth. The company has a solid track record of beating earnings estimates, which may lead to positive market sentiment.
Bull Case
If Envista exceeds the EPS estimate, it could indicate robust demand for its products and efficient cost management, potentially driving the stock higher.
Bear Case
Conversely, if the company misses its EPS or revenue targets, it could raise concerns about market demand and operational challenges, leading to a decline in stock price.
EPS
$0.31Earnings per share is a critical measure of profitability and will indicate how well the company is managing costs and generating income.
Revenue
$680MTotal revenue reflects the company's sales performance and demand for its products, which is essential for assessing growth.
The print will turn on these two things.
Q1
Will EPS exceed the consensus estimate of $0.31?
A beat on EPS could reinforce investor confidence and indicate strong operational performance.
Q2
How does management view revenue growth in light of current market conditions?
Insights into revenue growth will help investors gauge demand trends and the company's competitive positioning.
Why consensus could be wrong
The Street may underestimate Envista's ability to capitalize on emerging trends in dental technology, which could drive stronger-than-expected revenue growth.
Supporting Evidence
Envista has consistently beaten EPS estimates in recent quarters, indicating strong operational execution.
The company's focus on innovation in dental products may lead to increased market share, contrary to cautious market sentiment.
Key Risk
If revenue growth exceeds $700 million, it could significantly challenge the current consensus outlook.
Pre-commit to what would confirm each case.
This quarter, the focus is on Envista's ability to sustain its growth trajectory amid potential market challenges.
Bull Confirmed If
An EPS of $0.33 or higher would confirm strong demand and operational efficiency.
Bear Confirmed If
An EPS below $0.29 would raise concerns about market demand and profitability.
Implied Move
±N/A
There is no options market data available to gauge investor sentiment ahead of the earnings report.
Cross-company pattern from 30 similar setups.
Prior-quarter beat in Health Care
n=30Fade rate: 7 of 20 (35%)
This setup has occurred 30 times across Health Care in the last 2 years. 13 of 20 (65%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 5.9%, with a raw directional average of +2.1% (modestly positive historical bias).
Likely market behavior by outcome — not investment advice.
Beat & Raise
If Envista beats expectations, history suggests a potential stock increase of around 1% on the following day, confirming positive market sentiment.
In-Line / Cautious
If results are in line with expectations, the stock may see muted movement as investors await further guidance from management.
Miss
A miss on earnings could lead to a decline of approximately 1.28% based on historical patterns, reflecting investor disappointment.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
PARAMOUNT SKYDANCE C Class B
May 4, 2026